The United States Molecular Imaging Market is projected to grow from US$ 2.40 billion in 2024 to US$ 3.45 billion by 2033, ...

Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...

Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased ...

For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis ...

Even though years have passed since the start of the COVID-19 pandemic, the effects of infection with SARS-CoV-2 are still not completely understood. This is especially true for long COVID, a chronic ...

MBI is a nuclear medicine imaging technique that uses a radioactive tracer to highlight cancerous cells, and has been shown ...

High-density lipoproteins (HDL), also known as "good cholesterol," remove excess cholesterol from the body's tissues and ...

Lantheus Holdings, Inc. has announced an agreement to acquire Life Molecular Imaging Ltd. for $350 million upfront, with potential earn-outs of up to $400 million. This acquisition enhances Lantheus' ...

SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration with the Brain Health Alliance as an imaging site in the nationwide EPSMS ...

For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis (DBT) increases overall and invasive cancer detection.